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r 5 6  C h a n i e r  9
S u m m a r y  a n d  f u t u r e  p e r s p e c t i v e s
T h i s  t h e s i s  d e s c r i b e s  w a y s  t o  t a r g e t  e n d o t h e l i a l  c e l l s  t o  e n h a n c e  a n t i - t u m o r  e f f e c t s  o f  c y t o -
s t a t i c s  w i t h  a s  l e s s  a s  p o s s i b l e  e f f e c t  t o  n o r m a l  q u i e s c e n t  e n d o t h e l i a l  c e l l s .
A n t i - a n g i o g e n i c  t h e r a p y  i s  a  n e w  a n t i - t u m o r  t r e a t m e n t  m o d a l i t y ,  w h i c h  i s  c u r r e n t l y  i n
t h e  p h a s e  o f  c l i n i c a l  t e s t i n g .  A i m  o f  t h i s  t r e a t m e n t  i s  t o  b l o c k  a n g i o g e n e s i s  e i t h e r  b y  e . g .
endothe l ia l  cy to tox ic i ty  o r  inh ib i t ion  o f  endothe l ia l  g rowth  fac to rs .
l n  c h a p t e r  z ,  " a c c i d e n t a l  a n t i - a n g i o g e n e s i s "  a s  a  n e w  t r e a t m e n t  m o d a l i t y  w i t h  c l a s s i c
c h e m o t h e r a p e u t i c  d r u g s  i s  e x p l o r e d .  A  n u m b e r  o f  c h e m o t h e r a p e u t i c  d r u g s  u s e d  i n  t h e  t r e a t -
m e n t  f o r  s e v e r a l  a d v a n c e d  s o l i d  t u m o r s  i s  l i n k e d  t o  c a r d i o v a s c u l a r  t o x i c i t y .  B a s e d  o n  t h e i r
t o x i c i t y  o n  n o r m a l  e n d o t h e l i a l  c e l l s  a t  u l t r a - l o w  c o n c e n t r a t i o n s  e e n  i n  h u m a n  u m b i l i c a l  v e i n
e n d o t h e l i a l  c e l l  ( H U V E C )  a n d  m u r i n e  x e n o g r a f t  m o d e l s ,  c h e m o t h e r a p e u t i c  d r u g s  p o s s e s s  a n
a n t i - a n g i o g e n i c  p o t e n t i a l  t o w a r d s  t h e  r a p i d l y  d i v i d i n g  t u m o r  e n d o t h e l i a l  c e l l s .  C l i n i c a l  t r i a l s
w i t h  " m e t r o n o m i c  d o s i n g " - b a s e d  r e g i m e n s  ( m o r e  f r e q u e n t  d o s i n g  i n  l o w  c o n c e n t r a t i o n s )  t o
s u b s t a n t i a t e  t h i s  p o t e n t i a l  a r e  r e v i e w e d .  T h i s  n e w  m o d a l i t y  m i g h t  l e a d  t o  l o n g - t e r m  s u r v i v a l
a n d  h i g h e r  t u m o r  r e s p o n s e  r a t e .
A B T - 5 r o ,  a  n o n a p e p t i d e  d e r i v e d  f r o m  t h e  n a t u r a l l y  o c c u r r i n g  a n g i o g e n e s i s  i n h i b i t o r
t h r o m b o s p o n d i n - r ,  i s  a  n e w  a n t i - a n g i o g e n i c  a g e n t .  I n  p r e c l i n i c a l  t u m o r  m o d e l s , 7 5 % o  o f  t h e
m a x i m a l  a c t i v i t y  w a s  a c h i e v e d  w h e n  p l a s m a  A B T - 5 r o  c o n c e n t r a t i o n s  e x c e e d e d  r o o  n g / m L  f o r
more  than 3  hours  a  day .  We per fo rmed a  phase I  s tudy ,  descr ibed in  chapter  3  w i th  ABT-5ro
i n  p a t i e n t s  w i t h  a d v a n c e d  s o l i d  t u m o r s .  A B T - 5 r o  w a s  a d m i n i s t e r e d  s u b c u t a n e o u s l y  a s  c o n -
t i n u o u s  i n f u s i o n  t o o  m g l z 4  h o u r s  a n d  a s  b o l u s  i n j e c t i o n s  1 o o ,  2 o o  a n d  z 6 o  m g  o n c e  d a i l y
a n d  5 o  a n d  r o o  m g  t w i c e  d a i l y  s u b c u t a n e o u s l y  i n  c y c l e s  o f  z 8  d a y s .  B l o o d  a n d  u r i n e  s a m p l e s
f o r  p h a r m a c o k i n e t i c  a n d  - d y n a m i c  a n a l y s e s  w e r e  c o l l e c t e d .  A n t i - t u m o r  a c t i v i t y  w a s  e v a l u -
a ted  a t  regu la r  in te rva ls .  Th i r ty -n ine  pa t ien ts  rece ived a  to ta l  o f  rz6  cyc les ,  w i th  a  med ian
n u m b e r  o f  t w o  c y c l e s .  A d m i n i s t r a t i o n  o f  A B T - 5 r o  b y  c o n t i n u o u s  i n f u s i o n  w a s  h a m p e r e d  b y
o n s e t  o f p a i n f u l  s k i n  i n f i l t r a t e s  a t  t h e  s u b c u t a n e o u s  i n f u s i o n  s i t e  a n d  n o  d o s e  e s c a l a t i o n  w a s
p e r f o r m e d .  I n  t h e  b o l u s  i n , j e c t i o n  r e g i m e n s ,  t h e  m o s t  c o m m o n l y  o b s e r v e d  t o x i c i t i e s  w e r e
m i l d  t o  m o d e r a t e  r e a c t i o n s  a t  t h e  i n j e c t i o n  s i t e  a n d  f a t i g u e .  T h e  m a x i m u m  t o l e r a t e d  d o s e
w a s  n o t  r e a c h e d ,  6 u t  z 6 o  m g  o n c e  d a i l y  w a s  d e f i n e d  a s  t h e  m a x i m u m  c l i n i c a l l y  p r a c t i c a l
d o s e .  A B T - 5 r o  p h a r m a c o k i n e t i c s  w a s  l i n e a r  a c r o s s  d o s a g e  r a n g e s  t e s t e d  a n d  t h e  p o t e n t i a l
t h e r a p e u t i c  t h r e s h o l d  w a s  a c h i e v e d  b y  a l l  d o s e  r e g i m e n s .  M e d i a n  s e r u m  b a s i c  f i b r o b l a s t
growth  fac to r  (bFCF)  leve ls  showed a  decrease f rom ro .9  be fore  to  3 .o  pg /mL 56 days  a f te r
s t a r t  o f  t r e a t m e n t  ( p = o . o l ) .  P r o l o n g e d  s t a b l e  d i s e a s e ,  l a s t i n g  m o r e  t h a n  f i v e  c y c l e s ,  w a s
o b s e r v e d  i n  s i x  p a t i e n t s .
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T h e  f a v o r a b l e  t o x i c i t y  p r o f i l e ,  t h e  l i n e a r  a n d  t i m e - i n d e p e n d e n t  p h a r m a c o k i n e t i c s  w i t h
b i o l o g i c a l l y  r e l e v a n t  p l a s m a  c o n c e n t r a t i o n s  r e a c h e d ,  t h e  s i g n i f i c a n t  n u m b e r  o f  p a t i e n t s  w i t h
p r o l o n g e d  s t a b l e  d i s e a s e  a n d  t h e  c o n v e n i e n t  w a y  o f  d o s i n g  m a k e  A B T - 5 r o  a n  i n t e r e s t i n g
compound fo r  fu r ther  s tud ies .
l n  c h a p t e r  4 ,  c h a n g e s  i n  t u m o r  m e t a b o l i s m  a n d  t u m o r  p e r f u s i o n  a s  e a r l y  r e s p o n s e  m a r k -
e r s  i n  d r u g  d e v e l o p m e n t  P E T  s c a n n i n g  w a s  s t u d i e d  p e r f o r m e d  a s  p a r t  o f  t h i s  p h a s e  l t r i a l
w i t h  t h e  A B T - 5 r o .  N i n e  p a t i e n t s ,  w h o  r e c e i v e d  A B T - 5 r o ,  u n d e r w e n t  P E T  s c a n s  c o n s i s t i n g  o f
a  [ '5O]H.O and [ '8F ] f luorodeoxyg lucose (FDC)  s tudy  one day  be fore  and zz  days  a f te r  s ta r t  o f
ABT-5ro  t rea tment .  PET data  were  ana lyzed us ing  reg ion-  and vo lume-o f - in te res t  ana lys is ,
resu l t ing  in  a  mean metabo l ic  ra te  o f  g lucose and per fus ion  index .  Data  werecompared w i th
CTscans assessed on  day  t  and a f te r  56  days  o f  t rea tment .  The average mean metabo l ic  ra te
o f  g l u c o s e  o n  d a y  r  o f  t u m o r  t i s s u e  w a s  o . 4 3  +  o . 2 3  v e r s u s  o . 0 7 2  +  o . 0 7  F m o l  g l u c o s e / m i n .
m L f o r  b a c k g r o u n d  t i s s u e .  T h e  m e a n  c h a n g e  i n  m e a n  m e t a b o l i c  r a t e  o f  g l u c o s e  w a s  + 3 . 2 Q / o
x  t5o / "  fo r  tumor  t i ssue and +o: t7"  +  z4%" fo r  background ac t iv i t y  and the  average decrease
i n  p e r f u s i o n  i n d e x  w a s  - 7 . 3 y "  t  r 3 . 9 % .  N e i t h e r  c h a n g e s  i n  m e t a b o l i c  r a t e  o f  g l u c o s e  n o r
c h a n g e s  i n  p e r f u s i o n  i n d e x  c o r r e l a t e d  w i t h  v o l u m e  c h a n g e s  a s  a s s e s s e d  b y  C T  s c a n s  o n  d a y
5 6 .  P E T  s c a n n i n g  u s i n g  H . [ ' s O ] O  a n d  [ ' 8 F ] F D C  w a s  f e a s i b l e ,  b u t  c o u l d  n o t  d e m o n s t r a t e  a n
ef fec t  o f  ABT-5ro  on  tumor  per fus ion  or  metabo l ism in  th is  s tudy .
U n t i l  n o w ,  m o n o t h e r a p y  w i t h  a n g i o g e n e s i s  i n h i b i t o r s  s h o w  a  l i m i t e d  r e s p o n s e  r a t e ,  w h i l e
c o m b i n a t i o n  w i t h  c h e m o t h e r a p y  m a y  i n c r e a s e  t h e  p o t e n t i a l  a n t i - t u m o r  a c t i v i t y .
I n  s e v e r a l  t u m o r  t y p e s  s u c h  a s  c e r v i c a l  c a n c e r  a n d  h e a d  a n d  n e c k  c a n c e r ,  t h e  a d d i t i o n
o f  c h e m o t h e r a p y  w i t h  s t a n d a r d  r a d i o t h e r a p y  i m p r o v e d  r e s p o n s e  a n d  s u r v i v a l  r a t e s  c o m -
p a r e d  t o  r a d i o t h e r a p y  a l o n e .  I n  c h a p t e r  5 ,  a  s t u d y  i s  d e s c r i b e d  i n  w o m e n  w i t h  c e r v i c a l  c a n c e r
t r e a t e d  w i t h  s t a n d a r d  r a d i a t i o n  t h e r a p y  i n  c o m b i n a t i o n  w i t h  a  s t a n d a r d - d o s e  c a r b o p l a t i n
a n d  e s c a l a t i n g  p a c l i t a x e l  d o s e s .  T h e  a i m  o f  t h i s  s t u d y  w a s  t o  e n h a n c e  a n t i - t u m o r  e f f i c a c y  o f
the  s tandard  rad io therapy  by  add ing  chemotherapeut ic  d rugs  w i th  an t i -ang iogen ic  po ten t ia l ,
n a m e l y  m e t r o n o m i c  d o s e d  c a r b o p l a t i n  a n d  p a c l i t a x e l .  I n  a n  a n i m a l  m o d e l  i t  w a s  r e c e n t l y
shown tha t  mic rovascu la tu re  damage regu la tes  tumor  ce l l  response to  rad ia t ion  (Carc ia -
B a r r o s  M  e t  a l .  S c i e n c e  2 o o j i  3 o o ' .  r r 5 5 - r r 5 9 ) .  E i g h t  w o m e n  w i t h  c e r v i c a l  c a n c e r  s t a g e  l B z
-  l V A w e r e  t r e a t e d  w i t h  s t a n d a r d  r a d i a t i o n  t h e r a p y  i n  c o m b i n a t i o n  w i t h  s t a n d a r d  c a r b o p l a t i n
( a r e a  u n d e r  t h e  c u r v e ,  A U C  :  2 ,  o n c e  w e e k l y ,  x  6  t i m e s )  a n d  e s c a l a t i n g  d o s e s  o f  p a c l i t a x e l
( 6 o  m g l m ' ,  o n c e  w e e k l y ,  x  4  t i m e s ,  t h e n  x  5  t i m e s  a n d  x  6  t i m e s ) .  A t  t h e  l o w e s t  d o s e  l e v e l ,
f o u r  w e e k l y  p a c l i t a x e l  c y c l e s  i n  s i x  p a t i e n t s ,  t h r e e  d e v e l o p e d  g r a d e  3  d i a r r h e a  a n d  o n e  s e v e r e
rad ia t ion  en ter i t i s  severa l  weeks  a f te r  rad io therapy .  Two pat ien ts  d id  no t  ach ieve  comple te
remiss ion  and underwent  add i t i ve  sa lvage hys terec tomy.  A l l  pa t ien ts  remained f ree  o f  loca l
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r e c u r r e n c e ,  b u t  o n e  p a t i e n t  h a d  d i s t a n t  m e t a s t a s e s  a f t e r  r j  m o n t h s  w i t h  a  o n g o i n g  m e d i a n
f o l l o w - u p  o f  z 6  m o n t h s  ( r a n g e ,  1 1 .  -  3 1 .  m o n t h s ) .
I n  c o n c l u s i o n ,  i t  w a s  o b s e r v e d  t h a t  s t a n d a r d  p e l v i c  r a d i o t h e r a p y  i n  c o m b i n a t i o n  w i t h
w e e k l y  c a r b o p l a t i n  a n d  p a c l i t a x e l  i s  p o o r l y  t o l e r a t e d  d u e  t o  d o s e - l i m i t i n g  d i a r r h e a .  T h i s  i s  n o t
a  f e a s i b l e  r e g i m e n  f o r  f u r t h e r  s t u d i e s .
C h a p t e r  6  e x p l o r e s  a n o t h e r  w a y  o f  m e t r o n o m i c  d o s i n g  b y  a d m i n i s t r a t i n g  t o p o t e c a n  i n t r a -
p e r i t o n e a l l y  r e s u l t i n g  i n  a  s e m i - c o n t i n u o u s  i n f u s i o n  i n  s t e a d  o f  b o l u s  i n t r a v e n o u s  i n j e c t i o n s .
P a t i e n t s  w i t h  a d v a n c e d  o v a r i a n  c a n c e r  r e c e i v e d  c a r b o p l a t i n  a n d  p a c l i t a x e l  i n t r a v e n o u s l y
i n  c o m b i n a t i o n  w i t h  e s c a l a t i n g  d o s e s  t o p o t e c a n  i n t r a p e r i t o n e a l l y  a s  f i r s t - l i n e  t r e a t m e n t .
T h e  m a x i m a l  t o l e r a t e d  d o s e  t o p o t e c a n ,  t h e  p h a r m a c o k i n e t i c s  o f  t o p o t e c a n  a n d  t h e  t o x i c -
i t y  p ro f i le  o f  the  t rea tment  reg imen were  s tud ied .  Women wi th  advanced ovar ian  cancer
s tage l lB  -  lV  rece ived 6  cyc les  o fs tandard  doses  o f in t ravenous carbop la t in  and pac l i taxe l
i n  c o m b i n a t i o n  w i t h  e s c a l a t i n g  d o s e s  i n t r a p e r i t o n e a l  t o p o t e c a n  a s  f i r s t - l i n e  t r e a t m e n t .  T h e
pro jec ted  dose s teps  o f  in t raper i tonea l  topotecan were  to ,  15 ,2o  and 25  mglm, .  Topotecan
p h a r m a c o k i n e t i c s  i n  p e r i t o n e a l  f l u i d  a n d  p l a s m a  w a s  s t u d i e d  d u r i n g  t h e  f i r s t  c y c l e .  T u m o r
resPonse was eva lua ted  a f te r  t rea tment  comple t ion .  Twenty -one pa t ien ts  en tered  th is  t r ia l .
F e b r i l e  n e u t r o p e n i a ,  t h r o m b o c y t o p e n i a  r e q u i r i n g  p l a t e l e t  t r a n s f u s i o n  a n d  f a t i g u e  g r a d e  3
w e r e  d o s e - l i m i t i n g  a t  t o p o t e c a n  d o s e  l e v e l  z 5  m g l m ' i n t r a p e r i t o n e a l .  N a u s e a ,  v o m i t i n g ,
p a i n ,  d i a r r h e a ,  a l o p e c i a  a n d  n e u r o p a t h y  w e r e  f r e q u e n t ,  b u t  n o t  d o s e - l i m i t i n g .  T o p o t e c a n  z o
m g l m ' i n t r a p e r i t o n e a l  w a s  c o n s i d e r e d  t o  b e  t h e  m a x i m u m  t o l e r a t e d  d o s e .  P h a r m a c o k i n e t i c
d a t a  w e r e  c o m p a r a b l e  t o  t h o s e  o f  m o n o t h e r a p y  i n t r a p e r i t o n e a l  t o p o t e c a n .  T h e  p e r i t o n e a l :
p l a s m a  A U C  r a t i o  f o r t o t a l  t o p o t e c a n  w a s  4 6  +  3 o .  T h e  r 5  p a t i e n t s  w h o  c o m p l e t e d  t r e a t m e n t ,
had a  med ian  progress ion- f ree  surv iva l  o f  r7 -  months  ( range 4  -  39 . )
C o m b i n e d  w i t h  s t a n d a r d - d o s e s  o f  c a r b o p l a t i n  a n d  p a c l i t a x e l  i n t r a v e n o u s l y ,  t o p o t e c a n
2 0  m g l m ' i n t r a p e r i t o n e a l  i s  t h e  m a x i m u m  t o l e r a t e d  d o s e  a n d  t h e r e f o r e  r e c o m m e n d e d  f o r
f u r t h e r  s t u d i e s .  T h e  e f f i c a c y  o f  t h i s  r e g i m e n  s h o u l d  b e  f u r t h e r  e x p l o r e d  i n  a  p h a s e  l l l s t u d y .
Severa l  moda l i t ies  have been deve loped to  reduce s ide  e f fec ts  o f  chemotherapy  on  normal
t r s s u e s .
Ami fos t ine  is  dephosphory la ted  in  normal  t i ssues  to  a  f ree  th io i  w i th  cy topro tec t ive
poten t ia l  aga ins t  chemotherapy- induced tox ic i ty  w i thout  reduc ing  an t i - tumor  ac t iv i t y .
ln  chapter  7 ,  ovar ian  cancer  pa t ien ts  were  randomized to  rece ive  s tandard  pac l i taxe l  and
c a r b o p l a t i n  w i t h o u t  o r  w i t h  a m i f o s t i n e .  T h e  a i m  o f  t h e  r a n d o m i z e d ,  m u l t i - c e n t e r  p h a s e  l l
s tudy  was to  assess  the  e f f l cacy  o f  ami fos t ine  in  the  prevent ion  or  reduc t ion  o f  d rug- induced
tox ic i ty .  N ine ty  pa t ien ts  w i th  p r imary  ovar ian  cancer  were  randomized to  rece ive  pac l i taxe l
t 7 5  m g l m ' a n d  c a r b o p l a t i n  a t  a n  A U C : 6  f o r  s i x  c y c l e s ,  w i t h o u t  o r  p r e c e d e d  b y  a m i f o s t i n e
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7 4 0  m g l m z  a l l  i n t r a v e n o u s l y  a d m i n i s t e r e d .  T o x i c i t y  w a s  s c o r e d  a c c o r d i n g  t o  N C I - C T C  c r i t e -
r ia .  The mean percentua l  decrease o f  hemoglob in ,  leukocy te  and p la te le t  va lues  per  cyc le
showed no d i f fe rence be tween bo th  a rms.  No neuro tox ic i ty  was  observed in  4oo/ "  o f  the
cyc les  w i thout  ami fos t ine  versus  4gyo o f  the  cyc les  w i th  ami fos t ine ;  neuro tox ic i ty  g rade r
occurred in 45%o versus 48%", grade z in tz"/o versus 2?/o and grade 3 in z/" versus t%" of
a l l  cyc les  (overa l l  p  <  o .oor ) .  Nausea grade 2  was found in  zg / "  versus  6% (p :  o .oo7)  and
vomi t ing  grade 2  in  t%"  o f  cyc les  pac l i taxe l  p lus  carbop la t in  versus  87o o f  cyc les  pac l i taxe l
p l u s  c a r b o p l a t i n  a n d  a m i f o s t i n e  ( p  <  o . o o r ) .  O t h e r  n o n - h e m a t o l o g i c a l  t o x i c i t i e s  w e r e  m i l d
and no t  d i f fe ren t  in  bo th  a rms.  The ami fos t ine  in fus ion  was temporar i l y  ha l ted  in  f i ve  pa-
t i e n t s  i n  r o  c y c l e s  d u e  t o  h y p o t e n s i o n ,  b u t  w a s  n o t  r e d u c e d  o r  d i s c o n t i n u e d  f o r  t h i s  r e a s o n .
Qua l i t y  o f  l i fe  ques t ionna i res  a t  t rea tment  comple t ion  showed no d i f fe rence in  sub jec t ive ,
neuro tox ic i ty - re la ted  symptoms such as  pares thes ias ,  weakness  or  fa t igue.  A t  a  med ian  fo l -
low-up o f  z4  months ,  the  med ian  progress ion- f ree  surv iva l  fo r  carbop la t in -pac l i taxe l  and
c a r b o p l a t i n - p a c l i t a x e l  w i t h  a m i f o s t i n e i s z z  v e r s u s  r 6  m o n t h s  ( n . s . ) .  I n  a  p o o l e d - a n a l y s i s  o f
t h e  d a t a  o f  t h r e e  r a n d o m i z e d  s t u d i e s  i n  r 8 8  p a t i e n t s  r e c e i v i n g  c a r b o p l a t i n /  p a c l i t a x e l ,  t h e
add i t ion  o f  ami fos t ine  d imin ished the  r i sk  o f  deve lop ing  grade z -3  neuro tox ic i ty  (Odds Rat io
o . 3 ,  9 5 %  c o n f i d e n c e  i n t e r v a l  [ o . t  5 - o . 6 3 ] ) .
I n  c o n c l u s i o n ,  a m i f o s t i n e  s h o w e d  l i m i t e d  a c t i v i t y  i n  d i m i n i s h i n g  n e u r o t o x i c i t y ,  b u t  n o
ac t iv i t y  in  p revent ing  mye lo tox ic i ty  a f te r  t rea tment  w i th  pac l i taxe l  and carbop la t in .  There  was
no need fo r  d iscont inuat ion  or  reduc t ion  o f  ami fos t ine  due to  tox ic i ty .
R e c e n t l y  i n c r e a s i n g l y  d a t a  b e c a m e  a v a i l a b l e  o n  l o n g - t e r m  c a r d i o v a s c u l a r  t o x i c i t y  o b -
s e r v e d  i n  m a l e  g e r m  c e l l  c a n c e r  p a t i e n t s .  U n d e r s t a n d a b l e ,  d u e  t o  l o w  p a t i e n t  n u m b e r s ,
l i t t le  i s  known about  long- te rm e f fec ts  o f  women who are  t rea ted  w i th  c isp la t in -conta in ing
reg imens.  There fore ,  card iovascu la r  tox ic i ty  in  women t rea ted  w i th  c isp la t in -based chemo-
therapeut ic  schemes fo r  ovar ian  tumors  is  exp lo red  in  chapter  8 .  Twenty -one pa t ien ts  who
were  less  than 4o  years  o f  age a t  the  t ime o f  t rea tment  and were  a t  leas t  th ree  years  d isease-
f ree  a f te r  sa lp ingo-oophorec tomy fo l lowed by  c isp la t in -based chemotherapy  were  en tered
i n  t h e  s t u d y .  A  h i s t o r y  w a s  t a k i n g  a n d  p h y s i c a l  e x a m i n a t i o n  p e r f o r m e d .  W h o l e  b l o o d  c e l l
c o u n t s  a n d  l i v e r  a n d  k i d n e y  f u n c t i o n  w e r e  s t u d i e d .  A d d i t i o n a l l y ,  b l o o d  s a m p l e s  c o l l e c t e d
a f t e r  a n  o v e r n i g h t  f a s t  w e r e  a n a l y z e d  f o r  s e r u m  l i p i d ,  m a g n e s i u m ,  e n d o t h e l i a l  a n d  i n f l a m -
m a t o r y  m a r k e r  p r o t e i n s ,  t h y r o i d - s t i m u l a t i n g  h o r m o n e  a n d  f r e e  t h y r o x i n ,  i n s u l i n ,  g l u c o s e  a n d
p l a t i n u m  l e v e l s ,  w h i l e  c r e a t i n i n e  a n d  a l b u m i n  e x c r e t i o n  w a s  d e t e r m i n e d  i n  a  z 4 - h o u r  u r i n e
co l lec t ion .  Hypercho les tero laemia  was present  in  6z%" ,  obes i ty  in  z4 / " ,  hyper tens ion  in  t47o,
a n d  m i c r o a l b u m i n u r i a  i n  z 4 Y "  o f  t h e  p a t i e n t s .  C o m p a r e d  t o  t h e  b a c k g r o u n d  p o p u l a t i o n ,
m i c r o a l b u m i n u r i a  w a s  m o r e  f r e q u e n t  i n  t h e  l o n g - t e r m  c a n c e r  s u r v i v o r s  ( 2 3 . 8  v s .  3 . 2 % " ;  p  <
t 6 o  j  C h a p t c r  q
o . o 5 ) .  I n s u l i n  r e s i s t a n c e  w a s  f o u n d  i n  t 4 % "  o f  p a t i e n t s .  I n  a l l  p a t i e n t s ,  c i r c u l a t i n g  p l a t i n u m
l e v e l s  w e r e  d e t e c t e d  i n  s e r u m  a n d  u r i n e .  S e r u m  p l a t i n u m  l e v e l s  c o r r e l a t e d  w i t h  f o l l o w - u p
d u r a t i o n  ( r :  - o . 5 6 ;  p =  o . o o 9 )  a n d  r e n a l  f u n c t i o n  ( r :  - o . 6 r ;  p : o . o o 3 ) .
T h e s e  r e s u l t s  i l l u s t r a t e  t h a t  a l s o  i n  f e m a l e  c a n c e r  s u r v i v o r s  t r e a t e d  w i t h  c i s p l a t i n - b a s e d
c h e m o t h e r a p y  s i g n s  o f  v a s c u l a r  t o x i c i t y  m a y  d e v e l o p .
Conc lus ions  and  fu tu re  pe rspec t i ves
A n g i o g e n e s i s  a s  d e f i n e d  b y  F o l k m a n  i n  r 9 7 r  i s  a n  i n t r i n s i c  p a r t  o f  t h e  t u m o r  g r o w t h  a n d  c a -
p a c i t y  o f  a  t u m o r t o  m e t a s t a s i z e .  S t i l l  s e v e r a l  i s s u e s  r e m a i n  t o  b e  e x p l o r e d :  r )  t h e  b i o l o g y  o f
a n g i o g e n i c  p r o c e s s  a n d  f u l l  c h a r a c t e r i z a t i o n  o f  t u m o r  a s s o c i a t e d  e n d o t h e l i a l  c e l l s  n e e d  t o
be comple ted  fo r  iden t i f i ca t ion  o f  new drug  ta rge ts ;  z )  new prec l in ica l  mode ls  a re  requ i red
t o  p r e d i c t  a c c u r a t e l y  e n d o t h e l i a l  d a m a g e  a n d  c l i n i c a l  a c t i v i t y ;  3 )  s u r r o g a t e  m a r k e r s  n e e d  t o
be ident i f ied  to  charac ter ize  prognost ic  and pred ic t i ve  fac to rs  fo r  an t i - tumor  e f f i cacy ;  4 )  new
c o m b i n a t i o n  t r e a t m e n t s  o f  c h e m o t h e r a p y  w i t h  s p e c i f i c  a n t i - a n g i o g e n i c  a g e n t s  n e e d  t o  b e
e x p l o r e d .  B y  c o m b i n i n g  d i f f e r e n t  a g e n t s ,  s p e c i f i c  p r o b l e m s  e m e r g e :  r )  t h e  o p t i m a l  b i o l o g i c
a c t i v e  d o s e  t o  i n h i b i t  a n g i o g e n e s i s  i s  u s u a l l y  l e s s  t h a n  t h e  m a x i m u m  t o l e r a t e d  d o s e ,  n e w
met ronomic  schedu les  need to  be  s tud ied ;  z )  synergy  in  an t i - tumor  e f f i cacy  a f te r  add i t ion
o f  such an  agent  to  convent iona l  cy tos ta t i cs  cou ld  be  accompan ied  by  a  inc reased tox ic i ty
s u c h  a s  a n  i n c r e a s e  i n  r i s k  f o r  t h r o m b o e m b o l i c  e v e n t s .  C o m b i n i n g  t h e s e  l o w - d o s e  c y t o s t a t i c
s c h e d u l e s  w i t h  a  c u r r e n t l y  c o n s i d e r e d  l e s s  t o x i c  n a t u r a l l y  o c c u r r i n g  a n g i o g e n e s i s  i n h i b i t o r
s u c h  a s  T S P - r  m i g h t  c i r c u m v e n t  h e  t o x i c i t y  p r o b l e m .  T h e  d e v e l o p m e n t  o f  t h i s  n e w  w a y  o f
t rea tment  i s  s t i l l  a t  i t s  ear ly  s tage;  i t s  po ten t ia l  va lue  has  ye t  to  be  proven.
